Title |
Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group / Ralf-Dieter Hofheinz, Susanne Hegewisch-Becker, Volker Kunzmann, Peter Thuss-Patience, Martin Fuchs, Nils Homann, Ullrich Graeven, Nadine Schulte, Kirsten Merx, Michael Pohl, Swantje Held, Ralph Keller, Andrea Tannapfel, Salah-Eddin Al-Batran |
|---|---|
Involved |
Ralf-Dieter Hofheinz (Verfasser)
Susanne Hegewisch-Becker (Verfasser) Volker Kunzmann (Verfasser) Peter Thuss-Patience (Verfasser)
Martin Fuchs (Verfasser)
Nils Homann (Verfasser) Ullrich Graeven (Verfasser) Nadine Schulte (Verfasser) Kirsten Merx (Verfasser) Michael Pohl (Verfasser) Swantje Held (Verfasser) Ralph Keller (Verfasser) Andrea Tannapfel (Verfasser) Salah-Eddin Al-Batran (Verfasser) |
Published |
Würzburg: Universität Würzburg |
Extent |
Online-Ressource |
Language |
|
Country |
|
Topic |
|
Subject |
docetaxel |
DDC notation |
|
Persistent identifier |
urn:nbn:de:bvb:20-opus-347468 (URN) |
Further information |
In: International Journal of Cancer (2021) 149:1322-1331. https://doi.org/10.1002/ijc.33696 |
Record ID |
1351949810 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: